The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome‐Lysosome Fusion
Cell Proliferation · 2026-01 · 59 (1)
DOI: 10.1111/cpr.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 03.06.2025. Verfasst von Lin Ai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Ginsenosides, Mitophagy, Reperfusion Injury, Neuroprotective Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Postdoctoral Fellowship Program and China Postdoctoral Science Foundation, The Shanghai University of Traditional Chinese Medicine Budget Project, Shanghai Science and Technology Commission: Scientific and Technological Innovation Action Plan Medical Innovation Research Special Project.
Abstract (Originalsprache)
Ginsenoside Rg1 has shown promise in ameliorating cerebral ischemia–reperfusion injury (CIRI). However, its precise molecular mechanisms remain unclear. In this study, an in vitro CIRI model was established using SH‐SY5Y and SK‐N‐AS neuronal cell lines subjected to oxygen–glucose deprivation followed by reoxygenation (OGD/R). For the in vivo model, C57BL/6J mice underwent middle cerebral artery occlusion and subsequent reperfusion (MCAO/R). The protective effects of Rg1 against OGD/R injury were analysed using the CCK‐8 assay and the PI exclusion method. The in vivo neuroprotective effects of Rg1 against CIRI were evaluated using various assessments, including brain blood flow, neurological deficits, behavioural tests, TTC, H&E, Nissl and TUNEL staining. Mitophagy was assessed by detecting mitophagy‐initiating proteins via Western blotting, transmission electron microscopy, immunohistochemistry and immunofluorescence staining. Additionally, mitochondrial function was assessed by ATP measurement, the JC‐1 assay and MitoSOX‐based flow cytometry. Our results show that Rg1 significantly mitigated cell death caused by OGD/R and substantially enhanced cell viability in vitro. Moreover, Rg1 alleviated OGD/R‐induced mitochondrial dysfunction, as indicated by preserved mitochondrial membrane potential and decreased mitochondrial ROS levels. Mitophagy was induced after OGD treatment, which was subsequently inhibited by Rg1 during reperfusion. Mechanistically, Rg1 disrupted the fusion of mitophagosomes with lysosomes rather than inhibiting mitophagy initiation, leading to an accumulation of mitochondrial proteins and mitophagy‐initiating proteins. Notably, prolonged inhibition of mitophagy by Rg1 did not induce cytotoxicity or exacerbate mitochondrial dysfunction. Furthermore, administration of Rg1 in MCAO/R mice significantly improved brain blood reperfusion, reduced infarct volume, improved neurological deficits, preserved brain tissue integrity and decreased neuronal apoptosis. Consistent with the in vitro observations, Rg1 upregulated mitophagy‐related protein expression in MCAO/R mouse brain tissues, indicating potential inhibition of mitophagy. In conclusion, our study reveals that Rg1 significantly alleviates CIRI at least partially by suppressing mitophagy, specifically by impeding the fusion of mitophagosomes with lysosomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai, China.
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Feng Wang
Förderung
- the Postdoctoral Fellowship Program and China Postdoctoral Science Foundation
- The Shanghai University of Traditional Chinese Medicine Budget Project
- Shanghai Science and Technology Commission: Scientific and Technological Innovation Action Plan Medical Innovation Research Special Project
- Natural Science Foundation of Shanghai Municipality
- Shanghai Super Postdoctoral Program
- Discipline Construction of Pudong Health Bureau of Shanghai Discipline group of cerebrovascular system diseases
- CAI Dingfang Shanghai famous traditional Chinese Medicine inheritance studio
- Shanghai "Science and Technology Innovation Action Plan" Rising Star Program
Zitieren
APA
Ai, L., Ren, H., Wang, Y., Liu, M., Qiu, Y., Feng, J., Dai, R., Fu, W., Wang, Y., Xi, Z., Xu, H., & Wang, F. (2026). The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome‐Lysosome Fusion. Cell Proliferation, 59(1). https://doi.org/10.1111/cpr.70071
Vancouver
Ai L, Ren H, Wang Y, Liu M, Qiu Y, Feng J, et al. The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome‐Lysosome Fusion. Cell Proliferation. 2026;59(1). doi:10.1111/cpr.70071
BibTeX
@article{Ai2026,
author = {Ai, Lin and Ren, Hangui and Wang, Yuan and Liu, Mengfan and Qiu, Yufei and Feng, Jiling and Dai, Rongchen and Fu, Wang and Wang, Yongpeng and Xi, Zhichao and Xu, Hongxi and Wang, Feng},
title = {The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome‐Lysosome Fusion},
journal = {Cell Proliferation},
year = {2026},
volume = {59},
number = {1},
doi = {10.1111/cpr.70071}
}
EUVIMED